BERGENBIO ASA: ANNUAL REPORT 2020

Bergen, Norway – 25 February 2021: Reference is made to the notice on 23 February 2021 and the Board of Directors approval of BerGenBio ASA’s (OSE:BGBIO) Annual Financial statement. The Annual Report for 2020 is available on the Company’s website: https://www.bergenbio.com/investors/ 

– END – 

For further information, please contact:  

Richard Godfrey, CEO, BerGenBio ASA 
+47 917 86 304 

Rune Skeie, CFO, BerGenBio ASA 
rune.skeie@bergenbio.com 
+47 917 86 513 

Forward looking statements  

This announcement may contain forward-looking statements, which as such are not 
historical facts, but are based upon various assumptions, many of which are 
based, in turn, upon further assumptions. These assumptions are inherently 
subject to significant known and unknown risks, uncertainties and other 
important factors. Such risks, uncertainties, contingencies and other important 
factors could cause actual events to differ materially from the expectations 
expressed or implied in this announcement by such forward-looking statements. 

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.